[News]SML Genetree Participates in ‘MEDLAB Middle East’ in Dubai… Accelerating Global Market Expansion

2 day(s) ago

SML Genetree (CEO Dongsoo Lee) announced its participation in the 2025 MEDLAB Middle East exhibition, taking place from February 3 to 6 at the Dubai World Trade Centre in the United Arab Emirates, as part of its efforts to accelerate global market expansion.

MEDLAB Middle East is one of the largest diagnostic and medical device exhibitions in the world, with more than 180 countries participating. The event is expected to feature over 900 exhibitors and attract more than 30,000 visitors from across the globe. SML Genetree will operate a joint booth in collaboration with its local distributor, showcasing various innovative molecular diagnostic solutions, including the flagship NamuPlex respiratory diagnostic reagent. Through this exhibition, SML Genetree aims to directly engage with customers in the Middle East and strengthen its market presence.

Since 2023, SML Genetree has been reinforcing its presence in the Middle Eastern market through its partnership with a local distributor in Dubai. With this exhibition, SML Genetree plans to further expand sales in key Middle Eastern countries, including Saudi Arabia.

CEO Dongsoo Lee stated, “By participating in MEDLAB Middle East, we will strengthen our global expansion and contribute to improving human health by delivering innovative molecular diagnostic solutions to the Middle East. We envision 2025 as a pivotal year for our global revenue growth, solidifying our position in the global market.”


News excerpted from: https://n.news.naver.com/article/008/0005147997?sid=101

mobile background

NamuPlex™ is a registered trademark of SML Genetree Co.,Ltd. in South Korea.

Copyright ⓒ 2025 SML Genetree All rights reserved.

mobile background

NamuPlex™ is a registered trademark of SML Genetree Co.,Ltd. in South Korea.

Copyright ⓒ 2025 SML Genetree All rights reserved.